Interobserver variability in the application of the novel IASLC/ATS/ERS classification for pulmonary adenocarcinomas.
about
The new 2011 international association for the study of lung cancer/american thoracic society/european respiratory society classification of lung adenocarcinoma in resected specimens: clinicopathologic relevance and emerging issuesAdvances in lung adenocarcinoma classification: a summary of the new international multidisciplinary classification system (IASLC/ATS/ERS)Spatial and molecular resolution of diffuse malignant mesothelioma heterogeneity by integrating label-free FTIR imaging, laser capture microdissection and proteomicsPulmonary adenocarcinoma: implications of the recent advances in molecular biology, treatment and the IASLC/ATS/ERS classification.The revised lung adenocarcinoma classification-an imaging guideThe new IASLC/ATS/ERS lung adenocarcinoma classification from a clinical perspective: current concepts and future prospects.Using frozen section to identify histological patterns in stage I lung adenocarcinoma of ≤ 3 cm: accuracy and interobserver agreement.Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection.Predominant histologic subtype in lung adenocarcinoma predicts benefit from adjuvant chemotherapy in completely resected patients: discovery of a holy grail?Method for discriminating synchronous multiple lung cancers of the same histological type: miRNA expression analysis.Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image featuresCell cycle progression score is a marker for five-year lung cancer-specific mortality risk in patients with resected stage I lung adenocarcinoma.Size of Non-lepidic Invasive Pattern Predicts Recurrence in Pulmonary Mucinous Adenocarcinoma: Morphologic Analysis of 188 Resected Cases with Reappraisal of Invasion Criteria.Pathologic classification of adenocarcinoma of lung.Lung cancer: developments, concepts, and specific aspects of the new WHO classification.Classification of different patterns of pulmonary adenocarcinomas.Cytology nomenclature and 2015 World Health Organization classification of lung cancer.[Novel morphological and molecular aspects of lung cancer].Cytopathology of pulmonary adenocarcinoma with a single histological pattern using the proposed International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) classification.[Grading of lung cancer].Modified histologic classification as a prognostic factor in pulmonary adenocarcinoma.Interobserver reproducibility study of the histological patterns of primary lung adenocarcinoma with emphasis on a more complex glandular pattern distinct from the typical acinar pattern.Accuracy of the IASLC/ATS/ERS histological subtyping of stage I lung adenocarcinoma on intraoperative frozen sections.
P2860
Q26864736-E13CCDEA-0CFE-4171-AEB5-9F2A64B0DF0FQ27009370-AD150512-81EE-4DE3-A436-485C1240B01AQ30843287-BBA6644B-DD82-4C96-9BC6-C3E46DF5ECFEQ34404209-E0A0EA90-480C-4FDB-ABDD-61006CD02F8AQ34404257-371B802D-5F61-4624-8F3B-26DFDA4A2533Q34404266-528799ED-6FD5-4B59-82B5-4C712A919445Q35954585-8C8D688C-6030-4ACB-8863-1AD834ED361EQ36162509-A102F2D6-0E57-4C03-A158-43B4826EB909Q36474217-857E0753-CE1C-41D1-8630-A6E18C1C5929Q37165200-D89E60DE-A1BB-4406-B7B5-CC33DB5292D2Q37188409-512D7223-B905-4090-B69F-683DE43F5A60Q37376521-808F61BC-55CD-4EF2-B1E3-B87F97B20959Q37607959-4D075FDA-9FE8-4C2C-AE6D-EA3EF0674442Q38134347-2AB1AA6A-CE96-4C6C-B01B-FF451BAA3660Q38551599-9F900002-B54E-496A-9EB3-F813EAA5B5BDQ38574971-F7A44E99-E03D-4BB2-B81A-1DD2659BBCA9Q38606005-71FBCE26-A5CA-44DD-989E-E7F8E04035B1Q45264604-6D6ED782-F51D-4EB7-B558-DBF26D8E58F8Q49136811-9B0E8C8E-17D4-4A16-8102-DB586C350038Q53076283-B75B3269-94C1-498E-941F-BAF093C3807FQ53094087-F1CB5A8F-06F7-43E0-A2DC-577830D78F51Q53095908-C83510EF-C30C-4B45-A413-205E4927BB73Q53487553-AF799F2A-8BB7-4F30-BD5E-1290500BEFA3
P2860
Interobserver variability in the application of the novel IASLC/ATS/ERS classification for pulmonary adenocarcinomas.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Interobserver variability in t ...... for pulmonary adenocarcinomas.
@ast
Interobserver variability in t ...... for pulmonary adenocarcinomas.
@en
Interobserver variability in t ...... for pulmonary adenocarcinomas.
@nl
type
label
Interobserver variability in t ...... for pulmonary adenocarcinomas.
@ast
Interobserver variability in t ...... for pulmonary adenocarcinomas.
@en
Interobserver variability in t ...... for pulmonary adenocarcinomas.
@nl
prefLabel
Interobserver variability in t ...... for pulmonary adenocarcinomas.
@ast
Interobserver variability in t ...... for pulmonary adenocarcinomas.
@en
Interobserver variability in t ...... for pulmonary adenocarcinomas.
@nl
P2093
P1476
Interobserver variability in t ...... for pulmonary adenocarcinomas.
@en
P2093
Albrecht Stenzinger
Ann-Christin von Brünneck
Benjamin Goeppert
Hans Hoffmann
Iver Petersen
Judith Cortis
Philipp A Schnabel
P304
P356
10.1183/09031936.00219211
P577
2012-03-09T00:00:00Z